Welcome to CDC Stacks | Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children - 7435 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children
Filetype[PDF - 1.60 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose.
    Source:
    MMWR. Morbidity and mortality weekly report. 2008; 57(39):1078-9.
    Description:
    On June 24, 2008, the Food and Drug Administration licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) and inactivated poliovirus (IPV) vaccine, DTaP-IPV (Kinrix, GlaxoSmithKline Biologicals, Rixensart, Belgium)...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.60 MB]
  2. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Personal Author:
    Zangwill, Kenneth M. ; Wenger, Jay D. ; Sutter, Roland W. ; Hadler, Stephen C. ;
    Corporate Author:
    Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. ; National Center for Infectious Diseases (U.S.); National Center for Prevention Services (U.S.);
    Published:
    September 17, 1993
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1993; 42(RR-13):1-15.
    Description:
    These recommendations include information on two vaccines recently licensed for use among infants: Haemophilus b Conjugate Vaccine (PRP-T [ActHIB, OmniHIB]), manufactured by Pasteur M rieux Vaccins, and TETRAMUNE, manufactured by Lederle Laboratories...
    Status:
    current
    File Type:
    Filetype[PDF - 221.63 KB]
  3. Safety of Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations in Pregnancy
    Personal Author:
    Sukumaran, Lakshmi; McCarthy, Natalie L.; Kharbanda, Elyse O.; Weintraub, Eric; Vazquez-Benitez, Gabriela; McNeil, Michael M.; Li, Rongxia; Klein, Nicola P.; Hambidge, Simon J.; Naleway, Allison L.; Lugg, Marlene M.; Jackson, Michael L.; King, Jennifer P.; DeStefano, Frank; Omer, Saad B.; Orenstein, Walter A.;
    Published:
    Nov 2015
    Source:
    Obstet Gynecol. 126(5):1069-1074.
    Description:
    Objective : To evaluate the safety of co-administering tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) and influenza vaccines during pregnancy by comparing adverse events after concomitant and sequential vaccination. : Metho...
    File Type:
    Filetype[PDF - 256.13 KB]
  4. Preventing tetanus, diphtheria, and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Kretsinger, Katrina.; Broder, Karen R.; Cortese, Margaret M.; Joyce, Patricia; Ortega-Sanchez, Ismael; Lee, Grace M.; Tiwari, Tejpratap; Cohn, Amanda C.; Slade, Barbara A.; Iskander, John K.; Mijalski, Christina M.; Brown, Kristin H.; Murphy, Trudy V.;
    Corporate Author:
    National Immunization Program (Centers for Disease Control and Prevention; Centers for Disease Control and Prevention (U.S.), Immunization Safety Office.; United States, Advisory Committee on Immunization Practices;
    Published:
    December 15, 2006
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2006; 55(RR-17):1-37.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. v. 55, no. RR-17
    Description:
    On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the United States for persons aged 11--64 years (ADACEL®, manufactured by sanofi pasteu...
    Status:
    current
    File Type:
    Filetype[PDF - 418.34 KB]
  5. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012
    Personal Author:
    Sawyer, Mark; Liang, Jennifer L.; Messonnier, Nancy; Clark, Thomas A.;
    Corporate Author:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.
    Published:
    February 22, 2013
    Source:
    MMWR. Morbidity and mortality weekly report. 2013; 62(07):131-5
    Series:
    MMWR. Morbidity and mortality weekly report
    Description:
    In October 2011, in an effort to reduce the burden of pertussis in infants, the Advisory Committee on Immunization Practices (ACIP) recommended that unvaccinated pregnant women receive a dose of tetanus toxoid, reduced diphtheria toxoid, and acellula...
    Status:
    current
    File Type:
    Filetype[PDF - 91.36 KB]